Long-term follow-up of contacts exposed to multidrug-resistant tuberculosis in Victoria, Australia, 1995-2010

被引:44
作者
Denholm, J. T. [1 ,2 ]
Leslie, D. E. [3 ]
Jenkin, G. A. [4 ]
Darby, J. [5 ]
Johnson, P. D. R. [6 ]
Graham, S. M. [7 ,8 ]
Brown, G. V. [9 ]
Sievers, A. [3 ]
Globan, M. [3 ]
Brown, L. K. [10 ]
McBryde, E. S. [1 ,2 ]
机构
[1] Royal Melbourne Hosp, Victorian Infect Dis Serv, Parkville, Vic 3050, Australia
[2] Univ Melbourne, Dept Med, Parkville, Vic 3052, Australia
[3] Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia
[4] Monash Med Ctr, Dept Infect Dis, Clayton, Vic 3168, Australia
[5] St Vincents Hosp, Infect Dis Unit, Fitzroy, Vic 3065, Australia
[6] Austin Hlth, Dept Infect Dis, Melbourne, Vic, Australia
[7] Univ Melbourne, Ctr Int Child Hlth, Dept Paediat, Melbourne, Vic, Australia
[8] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia
[9] Univ Melbourne, Nossal Inst Global Hlth, Melbourne, Vic, Australia
[10] Dept Hlth Victoria, TB Control Unit, Melbourne, Vic, Australia
关键词
tuberculosis; drug resistant; contact tracing; public health; MYCOBACTERIUM-TUBERCULOSIS; RISK; COHORT;
D O I
10.5588/ijtld.12.0092
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
SETTING: The effectiveness of public health strategies following exposure to multidrug-resistant tuberculosis (MDR-TB) is not clear. OBJECTIVE: To perform long-term follow-up of MDR-TB contacts and review individual outcomes and management approaches. DESIGN: Retrospective review of MDR-TB contacts identified by the Victorian Department of Health from 1995 to 2010. Health records, including personal medical and pharmacy records and statewide clinical and laboratory TB databases, were searched to identify management strategies and individual outcomes. RESULTS: A total of 570 contacts of 47 MDR-TB cases were identified, with a total follow-up period of 3093 person-years of observation (PYO) since exposure. Of 570 contacts, 49 (8.6%) were considered likely to have been infected with Mycobacterium tuberculosis from index cases, and 11/49 (22.5%) of these were prescribed preventive therapy tailored to isolate susceptibility. No MDR-TB cases occurred in those receiving preventive treatment, while two cases were observed in those not treated (incidence 2878/100 000 PYO during the first 2 years post exposure). CONCLUSIONS: The risk of MDR-TB transmission to close contacts in this low-prevalence setting highlights the potential for public health strategies involving preventive treatment.
引用
收藏
页码:1320 / 1325
页数:6
相关论文
共 20 条
[1]   Risk of tuberculosis in close contacts of patients with multidrug resistant tuberculosis: a nationwide cohort [J].
Attamna, A. ;
Chemtob, D. ;
Attamna, S. ;
Fraser, A. ;
Rorman, E. ;
Paul, M. ;
Leibovici, L. .
THORAX, 2009, 64 (03) :271-271
[2]   Effect of drug resistance on the generation of secondary cases of tuberculosis [J].
Burgos, M ;
DeRiemer, K ;
Small, PM ;
Hopewell, PC ;
Daley, CL .
JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (12) :1878-1884
[3]  
Denholm J. T., 2010, TUBERC RES TREAT
[4]   Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons [J].
Diel, R. ;
Nienhaus, A. ;
Lange, C. ;
Meywald-Walter, K. ;
Forssbohm, M. ;
Schaberg, T. .
RESPIRATORY RESEARCH, 2006, 7 (1)
[5]   WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update [J].
Falzon, D. ;
Jaramillo, E. ;
Schuenemann, H. J. ;
Arentz, M. ;
Bauer, M. ;
Bayona, J. ;
Blanc, L. ;
Caminero, J. A. ;
Daley, C. L. ;
Duncombe, C. ;
Fitzpatrick, C. ;
Gebhard, A. ;
Getahun, H. ;
Henkens, M. ;
Holtz, T. H. ;
Keravec, J. ;
Keshavjee, S. ;
Khan, A. J. ;
Kulier, R. ;
Leimane, V. ;
Lienhardt, C. ;
Lu, C. ;
Mariandyshev, A. ;
Migliori, G. B. ;
Mirzayev, F. ;
Mitnick, C. D. ;
Nunn, P. ;
Nwagboniwe, G. ;
Oxlade, O. ;
Palmero, D. ;
Pavlinac, P. ;
Quelapio, M. I. ;
Raviglione, M. C. ;
Rich, M. L. ;
Royce, S. ;
Ruesch-Gerdes, S. ;
Salakaia, A. ;
Sarin, R. ;
Sculier, D. ;
Varaine, F. ;
Vitoria, M. ;
Walson, J. L. ;
Wares, F. ;
Weyer, K. ;
White, R. A. ;
Zignol, M. .
EUROPEAN RESPIRATORY JOURNAL, 2011, 38 (03) :516-528
[6]   Risk factors for multidrug resistant tuberculosis in Europe: a systematic review [J].
Faustini, A ;
Hall, AJ ;
Perucci, CA .
THORAX, 2006, 61 (02) :158-163
[7]  
Fred D., 2009, Morbidity and Mortality Weekly Report, V58, P253
[8]   Genetic diversity in the Mycobacterium tuberculosis complex based on variable numbers of tandem DNA repeats [J].
Frothingham, R ;
Meeker-O'Connell, WA .
MICROBIOLOGY-UK, 1998, 144 :1189-1196
[9]   Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis [J].
Gandhi, Neel R. ;
Nunn, Paul ;
Dheda, Keertan ;
Schaaf, H. Simon ;
Zignol, Matteo ;
van Soolingen, Dick ;
Jensen, Paul ;
Bayona, Jaime .
LANCET, 2010, 375 (9728) :1830-1843
[10]   Evidence of primary transmission of multidrug-resistant tuberculosis in the Western Province of Papua New Guinea [J].
Gilpin, Christopher M. ;
Simpson, Graham ;
Vincent, Stephen ;
O'Brien, Terry P. ;
Knight, Trevor A. ;
Globan, Maria ;
Coulter, Christopher ;
Konstantinos, Anastasios .
MEDICAL JOURNAL OF AUSTRALIA, 2008, 188 (03) :148-152